AstraZeneca AZN0.60%increase; green up pointing triangle plans to spend GBP650 million ($828.8 million) on vaccine programs and various other initiatives in the U.K. The pharmaceutical company ...

Additionally, we have even greater US investment in manufacturing and R&D planned, leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA. Overall, we are making excellent progress ...

AstraZeneca’s UK headquarters in Cambridge. Astrazeneca is to invest £650m in the UK, Chancellor Jeremy Hunt has announced in his Spring Budget. The pharmaceuticals giant will expand its ...

calling the Cambridge-headquartered pharma firm’s vaccine “a defective product,” according to the Daily Mail. AstraZeneca, which is contesting the claims, acknowledged in a February legal ...

Article ‘Count’ and ‘Share’ for AstraZeneca Cambridge based on listed parameters only. According to the parameters selected above, there are no articles from AstraZeneca Cambridge from 1 ...

The new functional genomics lab is the result of a partnership between Cambridge, AstraZeneca, and the U.K.’s Medical Research Council, and is part of the U.K.’s Human Functional Genomics ...

CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion. On a per-share basis, the Cambridge, Britain-based company ...

The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024. The chief executive of drugmaker AstraZeneca was handed a pa ...

Pascal Soriot, Chief Executive Officer, AstraZeneca, said ... leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA. Overall, we are making excellent progress toward our ambition ...